Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-013142
Filing Date
2018-03-30
Accepted
2018-03-30 19:19:07
Documents
1
Period of Report
2018-03-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6301
  Complete submission text file 0001127602-18-013142.txt   7657
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2045 LINCOLN HIGHWAY EDISON NJ 08817
Business Address
Conti Kurt G (Reporting) CIK: 0001653204 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 18726997